Australia's Therapeutic Goods Administration has approved the prescription of MDMA and psilocybin by authorized psychiatrists for PTSD and treatment-resistant depression. This decision, a first worldwide, has sparked a debate among experts. While some hail it as a breakthrough for patients unresponsive to conventional therapies, others express concerns about its implementation.
Australia's Therapeutic Goods Administration has approved the prescription of MDMA and psilocybin by authorized psychiatrists for PTSD and treatment-resistant depression. This decision, a first worldwide, has sparked a debate among experts. While some hail it as a breakthrough for patients unresponsive to conventional therapies, others express concerns about its implementation.
Share this Article
Recommended